Legislation enabling pharmacy professionals to supply take-home naloxone comes into force The decision to expand the list of healthcare professionals authorised to supply take-home naloxone aims to address the problem of opioid-related deaths making up the largest proportion of drug-related deaths in the UK.…
Nitazenes linked to 179 deaths in 12 months, government data show According to data analysis by the Office for Health Improvement and Disparities, protonitazene was linked to the most reported deaths — 73 out of 179.…
Pharmacist-led trial to assess impact of outreach on homeless people secures government funding Under the programme, pharmacists and third sector homelessness workers offer outreach to address health and social care needs in people experiencing homelessness.…
Deaths related to drug misuse in Scotland rose by almost 12% in 2023 The National Records of Scotland data show that opioids were implicated in 80% of the misuse-related deaths in 2023.…
First UK safe drug consumption room could open by September 2024, says local authority Exclusive: A spokesperson for Glasgow City Council said its safe drug consumption room may be able to open ahead of schedule.…
SNP pledges ‘framework’ for drug consumption rooms in manifesto As part of its manifesto for the UK general election, the Scottish National Party also said it would decriminalise drugs for personal use.…
Pregabalin prescribing increases by almost 25% since restrictions imposed Exclusive: Almost 670,000 patients in England were prescribed pregabalin when it was first reclassified in 2018/2019, compared with more than 820,000 patients in 2023/2024.…
Everything you need to know about xylazine Powerful veterinary tranquiliser xylazine has been implicated in a growing number of drug-related deaths in the United States. Researchers are now warning that it has entered the illicit drug market in the UK, with urgent action needed to protect people who use drugs from its harms.…
Roz Gittins: ‘The longer fitness-to-practise processes take, the longer registrants are left in purgatory’ As the new chief pharmacy officer for the General Pharmaceutical Council, Roz Gittins tells The Pharmaceutical Journal that she is bringing a fresh pair of eyes to the regulator’s fitness-to-practise process.…
Fourteen nitazenes made Class A controlled drugs The Home Office has made 15 new synthetic opioids Class A drugs “to prevent drug related deaths in the UK”.…
